NCT06836726 2026-01-28
EVO
University Health Network, Toronto
Phase 2 Not yet recruiting
Clinical Trials
4 trialsNCT07161778 2025-09-09
TRICREST
Barts & The London NHS Trust
Phase 2 Completed
NCT05445882 2024-04-02
N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT01540071 2021-05-14
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Io Therapeutics
Phase 2 Completed